Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/10635
Title: Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.
Authors: Huffam, Sarah
Jacups, Susan P
Kittler, Paulene
Currie, Bart J
Affiliation: Infectious Diseases Unit, Royal Darwin Hospital, Casuarina, NT, Australia. sarah.huffam@nt.gov.au.
Issue Date: Jun-2004
Citation: Tropical medicine & international health : TM & IH 2004-06; 9(6): 715-7
Abstract: In the tropical north of the Northern Territory, Australia, 25-50 patients are admitted to Royal Darwin Hospital (RDH) each year with Burkholderia pseudomallei infection, or melioidosis. Treatment consists of initial intensive therapy with 2-4 weeks of intravenous antibiotics. Clinical improvement may occur early and patients often prefer to be managed out of hospital in the Hospital in the Home (HITH). To evaluate safety and efficacy of HITH management of patients with melioidosis. A prospective observational study of our standard management which consists of 24 h infusions of ceftazidime infused through a peripherally inserted central catheter (PICC) line, plus oral sulphamethoxazole trimethoprim. Treatment is administered in the home, which may be in Darwin, regional areas or remote communities, or in a self-care unit located in the hospital grounds. From February 1998 to December 2001 150 patients were admitted to RDH with culture confirmed B. pseudomallei infection. Of these, 73 patients were treated with 24 h infusions of ceftazidime, of which 70 patients were managed by HITH. Complications of treatment include a PICC line complication rate of 10.6/1000 days in situ. Nine patients had relapse or recrudescence of disease, nearly all as a result of poor adherence to subsequent oral eradication therapy, these patients were all re-treated successfully. One patient remains infected with B. pseudomallei. This clinical outcome study suggests that out of hospital management of melioidosis with 24 h infusions of ceftazidime via a PICC line is safe and effective.
URI: http://docs.prosentient.com.au/prosentientjspui/handle/1/10635
DOI: 10.1111/j.1365-3156.2004.01244.x
ISSN: 1360-2276
Type: Journal Article
Subjects: Adolescent
Adult
Aged
Anti-Bacterial Agents
Catheterization, Central Venous
Ceftazidime
Child
Child, Preschool
Equipment Failure
Female
Humans
Infusions, Parenteral
Male
Melioidosis
Middle Aged
Northern Territory
Patient Compliance
Prospective Studies
Recurrence
Treatment Outcome
Home Infusion Therapy
Appears in Collections:NT Health digital library

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.